Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Survey of zolpidem efficacy in patients with brain injury
2007-000083-24Phase 2Withdrawn
- Sponsor
- Regen Therapeutics
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of zolpidem in traumatic brain injury (TBI), sponsored by Regen Therapeutics. Primary endpoints: Proportion of responders vs non-responders to zolpidem, Patterns of clinical response and 1 more. Planned start Feb 2007; status: withdrawn.
02
Drugs
zolpidem
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2007-000083-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000083-24.